Previous Article | Next Article 
Journal of Virology, June 1999, p. 4925-4930, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Identification of the Murine Mx2 Gene:
Interferon-Induced Expression of the Mx2 Protein from the Feral Mouse
Gene Confers Resistance to Vesicular Stomatitis Virus
Hee Kyung
Jin,1
Ayato
Takada,2
Yasuhiro
Kon,1
Otto
Haller,3 and
Tomomasa
Watanabe1,*
Laboratory of Experimental Animal
Science1 and Laboratory of
Microbiology,2 Graduate School of Veterinary
Medicine, Hokkaido University, Sapporo 060-0818, Japan, and
Department of Virology, Institute for Medical Microbiology and
Hygiene, University of Freiburg, D-79104 Freiburg,
Germany3
Received 4 November 1998/Accepted 9 March 1999
 |
ABSTRACT |
The mouse genome contains two related interferon-regulated genes,
Mx1 and Mx2. Whereas Mx1 codes for
the nuclear 72-kDa protein that interferes with influenza virus
replication after interferon treatment, the Mx2 gene is
nonfunctional in all laboratory mouse strains examined, since its open
reading frame (ORF) is interrupted by an insertional mutation and a
subsequent frameshift mutation. In the present study, we demonstrate
that Mx2 mRNA of cells from feral mouse strains NJL
(Mus musculus musculus) and SPR (Mus spretus) differs from that of the laboratory mouse strains tested. The Mx2 mRNA of the feral strains contains a single long ORF
consisting of 656 amino acids. We further show that Mx2 protein in the
feral strains is expressed upon interferon treatment and localizes to the cytoplasm much like the rat Mx2 protein, which inhibits vesicular stomatitis virus replication. Furthermore, transfected 3T3 cell lines
of laboratory mouse origin expressing Mx2 from feral
strains acquire slight resistance to vesicular stomatitis virus.
 |
INTRODUCTION |
Mammals have small families of
interferon (IFN)-responsive genes that code for structurally related
nuclear and cytoplasmic proteins collectively referred to as Mx
proteins (2, 18). The Mx1 and Mx2
genes in the mouse show a high degree of sequence similarity
(20) and they are both mapped to the same position on
chromosome 16. The nuclear Mx1 protein selectively blocks influenza virus multiplication (6). Cells from some laboratory strains synthesize Mx2 mRNA, but their open reading frames
(ORFs) are interrupted by an insertion, resulting in a translation
frameshift. Alignment of the nonfunctional mouse and functional
rat Mx2 sequences has identified a supernumerary cytosine
(C) residue at position 1366 of Mx2 mRNA (20). As
the Mx2 gene in commonly used strains of laboratory mice is
nonfunctional, the antiviral potential or other function of the Mx2
protein is unknown. Swiss mouse 3T3 cells expressing the Mx2
cDNA repaired by site-directed mutagenesis showed slight resistance to
the vesicular stomatitis virus (VSV) multiplication (24). In
this study, we found that the Mx2 gene from feral strains
was functional and could confer resistance to VSV infection.
 |
MATERIALS AND METHODS |
Mice.
Two laboratory inbred strains, BALB/c and C57BL/6J,
were purchased from Charles River Japan (Yokohama, Japan), and
laboratory inbred strain SL/NiA was provided by H. Hiai, Kyoto
University, Japan (1). The feral strains NJL (Mus
musculus musculus) and SPR (Mus spretus), maintained as
inbred lines in our laboratory, were originally captured in Denmark and
Spain, respectively.
Cell culture.
Fibroblast cultures were established from
16-day-gestation embryos of BALB/c, NJL, and SPR origin (5).
The cells were seeded in 75-cm2 tissue culture flasks
(Falcon Labware; Becton Dickinson, Oxnard, Calif.) at a density of
5 × 107 cells/flask in Dulbecco's modified Eagle's
medium (DMEM) supplemented with 10% fetal bovine serum (Gibco-BRL,
Gaithersburg, Md.). The medium was changed after one day, and the cells
were passaged every third day.
VSV strains.
Recombinant VSV carrying the green fluorescent
protein (GFP) gene instead of the G protein gene (VSV
G*-G) was
kindly provided by M. A. Whitt (University of Tennessee, Memphis,
Tenn.). Infectivity of VSV
G*-G on each 3T3 cell line was determined
by counting the number of GFP-expressing cells in 10 to 20 microscopic
fields (23).
Generation of full-length cDNA.
5' and 3' rapid
amplification of cDNA ends (RACE) was used with reverse transcription
(RT)-PCR to amplify mRNAs (3 µg) extracted from cultured macrophages
taken from each mouse strain, using a Marathon cDNA amplification kit
(Clontech, Palo Alto, Calif.) to generate double-stranded cDNA. The
double-stranded cDNA was ligated with the Marathon cDNA adaptor and
purified on a chromaspin-TE1000 column (Clontech) in a total volume of
100 µl. 5'- and 3'-RACE were performed by using the double-stranded
cDNA as a template with the Mx2 gene-specific primers GSP1
(5'-TTCTCGTCCACGATACTGCTTT-3') and GSP2
(5'-AAGTGAGGAGCTGCAGAAGTAC-3') and the adaptor primers AP1
(5'-CCATCCTAATACGACTCACTATAGGGC-3') and AP2
(5'-ACTCACTATAGGGCTCGAGCGGC-3'). Additional gene-specific
primers (5'GSP [5'-TTCTGTGGAAGGATAGAGGATACC-3'], 5RA seqF
[5'-AAGCCGGGAGGGGTGAGTATTG-3'], 5RA seqR
[5'-TCCGCACCACATCCACGACCTT-3'], 3'GSP
[5'-TCTGAGTGCTAGCACTTATCAGAGC-3'], 3'NES
[5'-CAGCAAGTAGATGGGTAGAGGA-3'], and 3'ESEQ
[5'-ATCCATGGCTGAGATCTTCC-3']) were generated based on the
sequences of progressively amplified 5'- and 3'-RACE products.
Sequencing and characterization of Mx2 cDNAs.
After RACE-PCR, amplified full-length cDNA fragments were cloned into
pGEM-T Easy vector (Promega, Madison, Wis.). The nucleotide sequences
were determined by using an ABI Prism dRhodamine Terminator cycle
sequencing kit (Perkin-Elmer, Norwalk, Conn.) with an ABI Prism 310 genetic analyzer (Perkin-Elmer). All of the sequences were compared
with that of the Mx2 mRNA reported earlier for BALB/c mice
(20), as analyzed by the GENETYX-MAC 7.2.0 program.
Construction of Mx2 expression vector.
After
RACE-PCR, the Mx2 cDNA fragments were cloned in the proper
orientation into the EcoRI site of plasmid pCI-neo
(Promega), which contains the human cytomegalovirus immediate-early
enhancer/promoter region and the neomycin phosphotransferase gene.
Transfection of 3T3 cells with Mx2 gene expression
plasmid.
3T3 cells (BALB/c embryonic fibroblasts), purchased from
Riken Cell Bank (Tsukuba, Japan), were grown in DMEM containing 10% (vol/vol) fetal bovine serum. After transfection with Lipofectin (Gibco-BRL), accomplished essentially as recommended by the
manufacturer, clones were selected in medium containing 500 µg of
G418 per ml (8, 16).
Mx2 RT-PCR.
Total 3T3 cell RNA (3 µg) was reverse
transcribed by using 200 U of SUPERSCRIPT II RT (Gibco-BRL) in a total
volume of 20 µl. The oligonucleotide primers for the Mx2
gene were 5'-AGTGAGGAGCTGCAGAAGTACG (bp 1158 to 1179) and
5'-ACTTGGTAGTTCTGTGGAGGTT (bp 1609 to 1588) for the RT-PCR.
As an internal control,
-actin mRNA was used in quantitative RT-PCR
experiments as described previously (7). The reaction
mixture for RT-PCR contained 20 mM Tris-HCl (pH 8.0), 100 mM KCl, 0.1 mM EDTA, 1 mM dithiothreitol, 0.2 mM deoxynucleoside triphosphate
(dNTP), 1 µM each primer, and 200 U of SUPERSCRIPT II. PCR was
performed in a DNA Thermal Cycler (Perkin-Elmer) with Taq
polymerase in 1.5 mM MgCl2, 0.2 µM each primer, and 20 µM each dNTP, as recommended by the supplier. The cycling profile was
comprised of an initial denaturating step for 5 min at 94°C followed
by 35 cycles at 94°C for 1 min, 60°C for 2 min, 72°C for 1 to 3 min, and a final extension at 72°C for 5 min.
Northern blot analysis.
Total RNA was isolated from
embryonic fibroblast cells by using ISOGEN (Nippon Gene, Tokyo, Japan)
as instructed by the manufacturer. RNA samples were electrophoresed on
formaldehyde gels, transferred, and hybridized as described previously
(17). Northern blots were performed by hybridization with
2,161 bp of the Mx2 cDNA (primers 5'GSP
[5'-TTCTGTGGAAGGATAGAGGATACC-3'] and 3'GSP
[5'-TCTGAGTGCTAGCACTTATCAGAGC-3']) labelled with
[32P]dCTP.
Immunofluorescence staining.
Cultured cells from peritoneal
macrophages prepared as described previously (11) were
treated for 18 h with 1,000 IU of mouse alpha/beta IFN
(IFN-
/
) (Sigma Chemical Co., St. Louis, Mo.)/ml. Macrophages were
then fixed with 3% paraformaldehyde in phosphate-buffered saline (PBS)
at pH 7.3 for 30 min. The cells were permeabilized with 0.5% Triton
X-100 in PBS, washed, and exposed to the monoclonal antibody 2C12,
which cross-reacts with Mx proteins from many species (22,
25). The cells were then washed, exposed to tetramethyl rhodamine
isothiocyanate-conjugated rabbit anti-mouse immunoglobulin G (Dako Co.,
Glostrup, Denmark), and mounted in 0.1 M Tris-HCl (pH 8.8) and
glycerol. Finally, the cells were viewed and photographed with a
BH2-RFCA microscope (Olympus Optical Co., Tokyo, Japan) equipped for epifluorescence.
Statistical analysis.
Data were expressed as means ± standard errors of the means. Statistical significance was evaluated by
using Fisher's protected least significant difference test.
P values less than 0.05 were considered statistically significant.
 |
RESULTS |
Characterization of cDNAs encoding the Mx2 gene in the
feral mouse strains.
Mx2 mRNAs of laboratory mouse strains
BALB/c and CBA/J have ORFs interrupted by an insertional mutation
(20). The Mx2 cDNA sequences from two feral
strains, NJL and SPR, were compared with that from the BALB/c strain.
It was indicated previously that the insertion of cytosine at position
1366 (C-1366) of BALB/c Mx2 mRNA resulted in two overlapping
ORFs encoding nonfunctional proteins. As shown in Fig.
1, C-1366 was also present in
Mx2 mRNA of two feral strains, but the adenine (A) at
position 1367 was deleted. Therefore, the Mx2 mRNA of feral
strains is composed of a single long ORF, and the putative Mx2 protein
that is a product of this ORF consists of 656 amino acids (Fig.
2).

View larger version (75K):
[in this window]
[in a new window]
|
FIG. 1.
The nucleotide and amino acid sequences of
Mx2 mRNA in cells from strains NJL and SPR of feral mice.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
FIG. 2.
Comparison of the nucleotide and amino acid sequences of
Mx2 proteins of BALB/c and wild-type strains NJL and SPR. The inserted
A residue at position 1367 is found in Mx2 mRNA of BALB/c
where the two long ORFs overlap. The Mx2 mRNA of the
wild-type strains contained a single long ORF, as the A was excluded.
|
|
Mx2 mRNA is highly expressed in IFN-
/
-activated
wild-type embryonic cells.
To determine the expression pattern of
Mx2, total RNAs derived from embryonic fibroblast cells of
BALB/c, NJL, and SPR strains were isolated and analyzed by Northern
blots. We treated the cells with 500 IU of mouse IFN-
/
per ml for
18 h and found that cells from both feral strains yielded higher
concentrations of 2.1-kb mRNAs than the BALB/c cells when total RNA was
hybridized with an Mx2 probe (Fig.
3). No detectable 2.1-kb mRNA was found
in BALB/c cells treated with IFN-
/
or in nontreated cells. NJL cells lacked a detectable level of 2.1-kb Mx2 mRNA in the
case of cells not treated with IFN-
/
, whereas SPR Mx2
mRNA was detected even in such cells.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 3.
Northern blot analysis of Mx2 expression.
Each lane contained 20 µg of total RNA isolated from embryonic cells.
Embryonic cells were treated with 500 IU of IFN- / per ml for
18 h or were left untreated. The Mx2 cDNA (top) was
used as a probe and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
cDNA (bottom) was used as a control for the probe.
|
|
Cytoplasmic localization of Mx2 expressed in two
wild-type strains.
The Mx1+ laboratory
mouse strains A2G and SL/NiA are resistant to influenza virus, and Mx1
protein is localized in the nucleus (4, 6, 10). We have
reported that the feral strains NJL and SPR also are positive for Mx1
protein (12). Rat Mx2 cDNA is closely related to
mouse Mx2 cDNA and codes for a cytoplasmic protein that
inhibits VSV but not influenza virus replication (14). We
therefore explored whether the Mx2 protein of the feral mouse strains
synthesized in response to IFN is localized in the cytoplasm.
Peritoneal macrophages were collected from each mouse strain and were
treated for 18 h with 1,000 IU of IFN-
/
per ml. Proteins
reacting with antibody 2C12, which cross-reacts with Mx1 and Mx2
proteins, accumulated both in the nuclei and in the cytoplasm of the
macrophages from feral strains NJL and SPR (Fig. 4). Additionally, protein reacting with
antibody 2C12 in the cytoplasm of the feral strains gave a punctate
staining pattern. In contrast, no staining was observed in macrophages
from BALB/c and C57BL/6 mice. These results suggested that the positive
expression and localization of Mx2 protein in the feral strains were
identical to those of the rat.

View larger version (98K):
[in this window]
[in a new window]
|
FIG. 4.
Detection of Mx2 protein in IFN-treated peritoneal
macrophages from feral mouse strains by immunofluorescence with the
anti-Mx monoclonal antibody 2C12 as described previously
(3). The cells shown are from the influenza virus-resistant
strain SL/NiA (a), wild-type strain SPR (b), wild-type strain NJL (c),
and susceptible strain C57BL/6 (d). All cells were treated with 500 IU
of IFN- / per ml for 18 h.
|
|
Permanently transfected cell lines constitutively express Mx2
proteins.
The Mx2 cDNA constructs with plasmid
Mx2-pCI-neo were transfected into 3T3 cell lines. The 3T3 cells are
derived from the BALB/c mouse strain lacking functional Mx
genes and therefore are unable to synthesize endogenous Mx proteins
(11, 19). Individual clones of stably transfected cells
containing the Mx2 cDNA constructed from feral strains NJL
and SPR were tested for Mx2 protein expression by immunofluorescence
staining with specific antibody 2C12. In each clone, 80 to 90% of
cells expressed Mx2 protein (Fig. 5). The
cytoplasm of the transfected 3T3 cells accumulating Mx2 protein from
feral strains gave a punctate staining pattern, whereas the cytoplasm
of cells transfected with control pCI-neo showed no staining.
Constitutive expression of these Mx2 proteins did not significantly
affect the growth rates of the transfected 3T3 cell lines.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 5.
Detection of Mx2 protein by immunofluorescence with the
anti-Mx monoclonal antibody 2C12 in stably transfected 3T3 cells
expressing the Mx2 gene from feral strains NJL and SPR after
IFN treatment. The transfected mouse 3T3 cells express the
Mx2 gene from feral strains (a) and control 3T3-pCI-neo (b).
Both cell lines were treated with 500 IU of IFN- / per ml for
18 h.
|
|
The relative concentrations of Mx2 mRNAs in transfected
cells with the Mx2 cDNA construct from feral strains (clones
N2, N4, S1, and S2) were much higher than those in the control cells
(Fig. 6).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 6.
Total RNA from transfected 3T3 cells was reverse
transcribed and PCR amplified by using Mx2 primers (top) and
-actin primers (bottom). Lanes: 1, 3T3 cells; 2 and 3, control
3T3-pCI-neo; 4 and 5, 3T3 cells expressing Mx2 from SPR (S1 and S2); 6 and 7, 3T3 cells expressing Mx2 from NJL (N2 and N4). An aliquot of
each PCR product was electrophoresed on a 1.2% agarose gel and
visualized with ethidium bromide.
|
|
VSV replication is inhibited in cells expressing Mx2 protein from
feral mouse strains.
Since Mx proteins have been shown to exert an
antiviral effect against influenza virus and VSV infection in vitro
(6, 8, 21), the infectivities of VSV
G*-G were examined on
each 3T3 cell clone expressing mouse Mx2 protein from feral strains. Of the cell lines expressing the cytoplasmic Mx2 protein of feral strains
NJL and SPR, N2, N4, S1, and S2 showed resistance to viral infection,
as they gave rise to significantly lower numbers of infected cells than
those of control 3T3 cells (Fig. 7).

View larger version (27K):
[in this window]
[in a new window]
|
FIG. 7.
The infectivity of VSV G*-G in Mx2
cDNA-transfected cell lines. S1 to S4, transfected 3T3 cells expressing
Mx2 of SPR; N1 to N4, transfected 3T3 cells expressing
Mx2 of NJL; C1 to C4, 3T3 cells transfected with pCI-neo.
The infectivity on 3T3 cells is expressed as 100%. Shown are mean
values ± standard errors of the means (n = 10).
Significance levels at P < 0.05 (*) and P < 0.01 (**) compared with 3T3 cells are indicated.
|
|
 |
DISCUSSION |
In all laboratory strains tested so far, the mouse Mx2
gene is nonfunctional (20). No Mx2 gene was
detected in IFN-
/
-treated cells from strain A2G, which is one of
the strains expressing the functional Mx1 gene. Cells from
BALB/c and other laboratory mouse strains tested synthesize low levels
of Mx2 mRNA under physiological conditions, but its ORF is
interrupted by a nucleotide insertion with subsequent frameshift
(20).
Our sequence analysis showed that the putative coding region of the
Mx2 mRNA in the feral strains NJL and SPR differed from that
of laboratory strains because of the absence of A at position 1367. Hence, the Mx2 mRNA of these two feral strains contains a
single long ORF and should be functional. It was indeed demonstrated by
Northern blotting that IFN-treated embryonic cells from feral strains
strongly expressed the Mx2 gene. In contrast, expression of
the BALB/c Mx2 gene was not detected even after treatment
with IFN-
/
. Immunostaining experiments indicated that Mx2 protein was localized in the cytoplasm, and a punctate staining pattern was
observed. Furthermore, by RT-PCR using an Mx2-specific
primer, it was confirmed that transfected 3T3 cell lines from
Mx2 cDNA from feral strains expressed a high level of
Mx2 mRNA. Therefore, we demonstrated a functional
Mx2 gene in the mouse, although it remains to be determined
how the Mx2 protein interferes with virus infection.
Rat cells synthesize three related proteins, Mx1, Mx2, and Mx3, upon
IFN treatment (14). Rat Mx1 protein is predominantly localized in the nucleus and protects cells against influenza virus but
only weakly against VSV. Rat Mx2 protein is cytoplasmic and protects
against VSV. Rat Mx3 is also cytoplasmic, but it lacks activity. Though
rat Mx2 differs from rat Mx3 in only eight amino acids (Leu-36,
Ala-190, Lys-232, Ser-518, Ser-561, Lys-564, Arg-588, and His-630),
mouse Mx2 matches rat Mx2 at four of these amino acids (Ala-190,
Ser-518, Ser-561, and Arg-588) and rat Mx3 at two of them (Val-36 and
Glu-232) (20). Johannes et al. (13) demonstrated
direct evidence of the presence of anti-VSV determinants in the C
terminus of rat Mx2, especially in the region between Arg-588 and
His-630 (15, 24). However, the change of His in rat Mx2
protein to Gln in the mouse protein at position 630 might be a very
drastic alteration, suggesting that this His residue plays a key role
in rat Mx2 protein. On the other hand, the cells transfected with mouse
Mx2 cDNA repaired by the exclusion of a C residue at
position 1366 showed a high degree of resistance to VSV, when the mouse
3-hydroxy-3-methylglutaryl coenzyme A reductase gene promoter was used
(24). In the present study, the degree of resistance of
Mx2-transfected cells was limited. This may be due to (i)
the His-to-Gln change at position 630 or (ii) the difference of the
promoter activity of expression vector and/or cell line used. It was
recently found that VSV is less Mx sensitive than members of
the Bunyaviridae family such as La Crosse virus, Hanta virus, and Rift Valley fever virus (9). It will be necessary to examine the antiviral potential of functional
Mx2-expressing cell lines against bunyavirus infections.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Laboratory of
Experimental Animal Science, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan. Phone: 81-11-706-5106. Fax: 81-11-717-7569. E-mail:
watanabe{at}vetmed.hokudai.ac.jp.
 |
REFERENCES |
| 1.
|
Abujiang, P.,
Y. Yamada,
O. Haller,
H. Kobayashi,
T. Kamoto,
L. M. Lu,
M. Ogawa,
A. Ishimoto,
H. Katoh,
K. Kanehira,
S. Ikegami,
M. Fukumoto, and H. Hiai.
1996.
The origin of SL family mice.
Lab. Anim. Sci.
46:410[Medline].
|
| 2.
|
Aebi, M.,
J. Fäh,
N. Hurt,
C. E. Samuel,
D. Thomis,
L. Bazzigher,
J. Pavlovic,
O. Haller, and P. Staeheli.
1988.
cDNA structures and regulation of two interferon-induced human Mx proteins.
Mol. Cell. Biol.
9:5062-5072.
|
| 3.
|
Arnheiter, H.,
S. Skuntz,
M. Noteborn,
S. Chang, and E. Meier.
1990.
Transgenic mice with intracellular immunity to influenza virus.
Cell
62:51-61[Medline].
|
| 4.
|
Arnheiter, H., and O. Haller.
1988.
Antiviral state against influenza virus neutralized by microinjection of antibodies to interferon-induced Mx proteins.
EMBO J.
7:1315-1320[Medline].
|
| 5.
|
Arnheiter, H., and P. Staeheli.
1983.
Expression of interferon dependent resistance to influenza virus in mouse embryo cells.
Arch. Virol.
76:127-137[Medline].
|
| 6.
|
Dreiding, P.,
P. Staeheli, and O. Haller.
1985.
Interferon-induced protein Mx accumulates in nuclei of mouse cells expressing resistance to influenza viruses.
Virology
140:192-196[Medline].
|
| 7.
|
Farina, S. F.,
L. J. Girard,
E. F. Vanin,
A. W. Nienhius, and D. M. Bodine.
1995.
Dysregulated expression of GATA-1 following retrovirus-mediated gene transfer into murine hematopoietic stem cells increases erythropoiesis.
Blood
86:4124-4133[Abstract/Free Full Text].
|
| 8.
|
Fortunati, E.,
A. Bout,
M. A. Zanta,
D. Valerio, and M. Scarpa.
1996.
In vitro and in vivo gene transfer to pulmonary cells mediated by cationic liposomes.
Biochim. Biophys. Acta
1306:55-62[Medline].
|
| 9.
|
Haller, O.,
M. Frese, and G. Kochs.
1998.
Mx proteins: mediators of innate resistance to RNA viruses.
Rev. Sci. Tech. O. I. E. (Off. Int. Epizoot.)
17:220-230.
|
| 10.
|
Haller, O.,
M. Acklin, and P. Staeheli.
1987.
Influenza virus resistance of wild mice: wild-type and mutant Mx alleles occur at comparable frequencies.
J. Interferon Res.
7:647-656[Medline].
|
| 11.
|
Haller, O.,
H. Arnheiter,
I. Gresser, and J. Lindenmann.
1979.
Genetically determined, interferon-dependent resistance to influenza virus in mice.
J. Exp. Med.
149:601-612[Abstract/Free Full Text].
|
| 12.
|
Jin, H. K.,
T. Yamashita,
K. Ochiai,
O. Haller, and T. Watanabe.
1998.
Characterization and expression of the Mx1 gene in wild mouse species.
Biochem. Genet.
36:311-322[Medline].
|
| 13.
|
Johannes, L.,
H. Arnheiter, and E. Meier.
1991.
Virus specificity of rat Mx2 protein depends on subcellular localization.
J. Interferon Res.
11:S50.
|
| 14.
|
Meier, E.,
G. Kunz,
O. Haller, and H. Arnheiter.
1990.
Activity of rat Mx proteins against a rhabdovirus.
J. Virol.
64:6263-6269[Abstract/Free Full Text].
|
| 15.
|
Noteborn, M.,
H. Arnheiter,
L. Richter-Mann,
H. Browning, and C. Weissmann.
1987.
Transport of the murine Mx protein into the nucleus is dependent on a basic carboxyl-terminal sequence.
J. Interferon Res.
7:657-669[Medline].
|
| 16.
|
Pavlovic, J.,
T. Zurcher,
O. Haller, and P. Staeheli.
1990.
Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human Mx A protein.
J. Virol.
64:3370-3375[Abstract/Free Full Text].
|
| 17.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 18.
|
Staeheli, P.
1990.
Interferon-induced proteins and the antiviral state.
Adv. Virus Res.
38:147-200[Medline].
|
| 19.
|
Staeheli, P.,
R. Grob,
E. Meier,
J. G. Sutcliffe, and O. Haller.
1988.
Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation.
Mol. Cell. Biol.
8:4518-4523[Abstract/Free Full Text].
|
| 20.
|
Staeheli, P., and G. Sutcliffe.
1988.
Identification of a second interferon-regulated murine Mx gene.
Mol. Cell. Biol.
8:4524-4528[Abstract/Free Full Text].
|
| 21.
|
Staeheli, P.,
O. Haller,
W. Boll,
J. Lindenmann, and C. Weissmann.
1986.
Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus.
Cell
44:147-158[Medline].
|
| 22.
|
Staeheli, P.,
P. Dreiding,
O. Haller, and J. Lindenmann.
1985.
Polyclonal and monoclonal antibodies to the interferon-inducible protein Mx of influenza virus-resistant mice.
J. Biol. Chem.
260:1821-1825[Abstract/Free Full Text].
|
| 23.
|
Takada, A.,
C. Robison,
H. Goto,
A. Sanchez,
K. G. Murti,
M. A. Whitt, and Y. Kawaoka.
1997.
A system for functional analysis of Ebola virus glycoprotein.
Proc. Natl. Acad. Sci. USA
94:14764-14769[Abstract/Free Full Text].
|
| 24.
|
Zurcher, T.,
J. Pavlovic, and P. Staeheli.
1992.
Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus.
Virology
187:796-800[Medline].
|
| 25.
|
Zurcher, T.,
J. Pavlovic, and P. Staeheli.
1992.
Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus.
J. Virol.
66:5059-5066[Abstract/Free Full Text].
|
Journal of Virology, June 1999, p. 4925-4930, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Anh, D. B. T., Faisca, P., Desmecht, D. J.-M.
(2006). Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains. Am. J. Physiol. Lung Cell. Mol. Physiol.
291: L426-L435
[Abstract]
[Full Text]
-
Faisca, P., Anh, D. B. T., Desmecht, D. J.-M.
(2005). Sendai virus-induced alterations in lung structure/function correlate with viral loads and reveal a wide resistance/susceptibility spectrum among mouse strains. Am. J. Physiol. Lung Cell. Mol. Physiol.
289: L777-L787
[Abstract]
[Full Text]
-
Welton, A. R., Chesler, E. J., Sturkie, C., Jackson, A. U., Hirsch, G. N., Spindler, K. R.
(2005). Identification of Quantitative Trait Loci for Susceptibility to Mouse Adenovirus Type 1. J. Virol.
79: 11517-11522
[Abstract]
[Full Text]
-
Spindler, K. R., Fang, L., Moore, M. L., Hirsch, G. N., Brown, C. C., Kajon, A.
(2001). SJL/J Mice Are Highly Susceptible to Infection by Mouse Adenovirus Type 1. J. Virol.
75: 12039-12046
[Abstract]
[Full Text]
-
Samuel, C. E.
(2001). Antiviral Actions of Interferons. Clin. Microbiol. Rev.
14: 778-809
[Abstract]
[Full Text]
-
Stojdl, D. F., Abraham, N., Knowles, S., Marius, R., Brasey, A., Lichty, B. D., Brown, E. G., Sonenberg, N., Bell, J. C.
(2000). The Murine Double-Stranded RNA-Dependent Protein Kinase PKR Is Required for Resistance to Vesicular Stomatitis Virus. J. Virol.
74: 9580-9585
[Abstract]
[Full Text]
-
Ko, J.-H., Jin, H.-K., Asano, A., Takada, A., Ninomiya, A., Kida, H., Hokiyama, H., Ohara, M., Tsuzuki, M., Nishibori, M., Mizutani, M., Watanabe, T.
(2002). Polymorphisms and the Differential Antiviral Activity of the Chicken Mx Gene. Genome Res
12: 595-601
[Abstract]
[Full Text]